When to remove pancreatic stents? new trial aims to find out
NCT ID NCT07346365
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will compare two different schedules for removing pancreatic stents placed during ERCP to prevent pancreatitis. One group will have the stent removed after 1-3 months, while the other will have it removed within 10 days. The goal is to see which timing leads to fewer complications and better outcomes for the 358 participants.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
pancreatic stent
What this could lead to
If successful, this could establish the safest timing for removing pancreatic stents after ERCP, reducing complications and follow-up procedures.
What could go wrong
This is an early-stage study that has not yet started recruiting. The results may not apply to all patients or stent types, and the optimal timing may vary by individual.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST ERCP PANCREATITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Johann Wolfgang Goethe-Universität Frankfurt am Main
Frankfurt, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••